Envista Holdings Corporation’s Quiet Period To Expire on October 28th (NASDAQ:NVST)

Envista’s (NASDAQ:NVST) quiet period will end on Monday, October 28th. Envista had issued 26,768,000 shares in its initial public offering on September 18th. The total size of the offering was $588,896,000 based on an initial share price of $22.00. During the company’s quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Several research firms recently issued reports on NVST. Stifel Nicolaus began coverage on shares of Envista in a research note on Monday, October 14th. They set a “buy” rating and a $34.00 price target on the stock. Jefferies Financial Group started coverage on shares of Envista in a research note on Monday, October 14th. They set a “buy” rating and a $34.00 price target on the stock. Goldman Sachs Group started coverage on shares of Envista in a research report on Monday, October 14th. They issued a “buy” rating and a $33.00 target price for the company. Robert W. Baird started coverage on shares of Envista in a research report on Monday, October 14th. They issued an “outperform” rating and a $33.00 target price for the company. Finally, Evercore ISI started coverage on shares of Envista in a research report on Monday, October 14th. They issued an “outperform” rating and a $35.00 target price for the company. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Envista presently has an average rating of “Buy” and a consensus target price of $32.50.

NVST opened at $28.24 on Wednesday. Envista has a 1-year low of $25.65 and a 1-year high of $29.74.

In related news, CFO Howard H. Yu bought 2,000 shares of the company’s stock in a transaction dated Friday, September 20th. The stock was bought at an average price of $22.00 per share, with a total value of $44,000.00. Also, CEO Amir Aghdaei bought 10,000 shares of the company’s stock in a transaction dated Friday, September 20th. The stock was bought at an average cost of $22.00 per share, with a total value of $220,000.00. Insiders bought a total of 13,000 shares of company stock valued at $286,000 in the last three months.

Envista Company Profile

Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands.

Featured Article: How do analysts define an oversold condition?

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.